Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Cell Reports. Medicine|February 2, 2022
Antibodies against viral nucleo-, phospho-, and X protein contribute to serological diagnosis of fatal Borna disease virus 1 infectionsBernhard Neumann, Klemens Angstwurm, Ralf A Linker, et al.Nature Communications|March 5, 2021
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitisJames A Hutchinson, Katharina Kronenberg, Paloma Riquelme, et al.Journal of Hepatology|July 23, 2017
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in miceShanshan Zhang, Xinhua Song, Dan Cao, et al.International Journal of Cardiology|June 1, 2022
SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stressMelina Tangos, Heidi Budde, Detmar Kolijn, et al.Cell Reports Methods|November 15, 2025
Cortical organoid-derived models of the melanoma brain metastatic niche enable prioritization of cancer-targeting drugsKim Krieg, Silvia Materna-Reichelt, Tobias Naber, et al.Nature Cancer|May 16, 2025
MCSP+ metastasis founder cells activate immunosuppression early in human melanoma metastatic colonizationSeverin Guetter, Courtney König, Huiqin Koerkel-Qu, et al.Molecular Oncology|October 5, 2024
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, et al.Cancer Letters|December 10, 2025
Lactic acid promotes an MDSC-like phenotype via HIF1α stabilization with impact on prognosis in renal cell carcinomaNathalie Babl, Florian Voll, Agnieszka Martowicz, et al.Proceedings of the National Academy of Sciences of the United States of America|November 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic nicheLaura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl, et al.Cell Reports|October 3, 2019
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint TherapyKathrin Renner, Christina Bruss, Annette Schnell, et al.Pageof 10